top of page

American Association for Cancer Research (AACR) Annual Meeting 2022


Summary

  • The American Association for Cancer Research (AACR) annual meeting takes place from April 8-13, 2022 online and in New Orleans

  • This meeting focuses on cancer research and sharing the latest advances in science and medicine

  • Several smid-cap biopharma companies in the BPIQ.com database are presenting clinical data this year

  • Keep an eye out next month for info on ASCO 2022 which features many more companies presenting clinical data in cancer indications

  • See our full forum post HERE with additional data on these presentations. Learn more here about subscribing.


 

Want to get Catalyst Events and stocks to watch sent directly to your inbox each week? sign up for our free weekly newsletter

 

AACR 2022 begins tomorrow (April 8) and runs through April 13th. "The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine." (https://www.aacr.org/meeting/aacr-annual-meeting-2022/). AACR 2022 is taking place online and in New Orleans, and a handful of smid-cap biopharma companies found on BPIQ.com are presenting clinical data this year.


While many companies are presenting preclinical data or non-clinical data, there are several companies that are presenting clinical trial data. See Table 1 which highlights these smid-cap biopharma companies presenting at AACR 2022. Multiple companies are presenting data from ongoing basket trials, and other cancers to be highlighted include glioblastoma, multiple myeloma, and head & neck cancers. All companies in this list are presenting data from Phase 1 or 2 trials, but GLSI will also be presenting their Phase 3 trial design.


AACR differs from ASCO in this aspect because of the higher prevalence of preclinical or nonclinical data presented at AACR, while many ASCO presentations focus on late stage clinical trials. Last year, many companies saw large stock changes when ASCO abstracts were announced, as well as during the medical conference. Keep an eye out on BPIQ.com for updates leading up to ASCO where we will focus on those companies reporting important data and which may be Big Movers for June.


See our full forum post HERE for more info on these AACR presentations and watch for upcoming data revolving around ASCO. (ASCO 2022 abstract titles to be released April 27, 2022 and majority of full abstracts released May 26, 2022)




Table 1. Smid-cap biopharma companies presenting clinical data at AACR



See full forum post HERE.

 

If you are serious about investing in biotech stocks BPIQ is the research companion that will take you to the next level.


Save yourself time by accessing our database of over 550 companies, 1,800+ of their drug assets, and tools including: Catalyst Calendar, Big Movers, Company Pipelines, and more!


 

See what our members are saying about us:


Mike from United States

“Really loving the site over the competitor... like the layout and speed over the competition...like the individual pages for each drug/treatment”

Carl from United States

“I like your service. I haven’t seen anyone else doing something similar...nothing like this available for retail.”

Essey from Canada

“Love what you’re doing, this website is awesome.”

James from United States

Great site and I see it’s a family run business, great job.”


0 comments

Comments


bottom of page